Of course these are just a few of the most frequent
questions, a wide range of other question are asked, and often we make
the diagnosis where others failed, giving you plenty of
recommendation on how to proceed.We
receive testemonial by the hundred every
months, you can read some on our sites or my physicians.com site since we
active advisor with surfdoc company
For available ongoing clinical studies please
contact Dr.I .Benayacheclick
here
�Study Phase
Most clinical trials
are designated as phase I, II, or III, based on the type of questions
that study is seeking to answer:
�In Phase I clinical trials, researchers test a new
drug or treatment in a small group of people (20-80) for the first time
to evaluate its safety, determine a safe dosage range, and identify side
effects.
�In Phase II clinical trials, the
study drug or treatment is given to a larger group of people (100-300) to
see if it is effective and to further evaluate its safety.
�In Phase III studies, the study drug or treatment is
given to large groups of people (1,000-3,000) to confirm its effectiveness,
monitor side effects, compare it to commonly used treatments, and collect
information that will allow the drug or treatment to be used safely.
�These phases are defined by the Food and Drug
Administration in the Code of Federal Regulation
